Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Eccles who wrote (14112)	11/15/2004 9:26:33 AM
From: Biomaven	of 52153

This thread virtually never deals with pink sheet companies (or even BB companies). 10c earnings on 1.9 billion shars implies earnings of $200m - that's patently ridiculous for a instant test company - they all struggle to make money, as margins are very low. Trinity Biotech would be best comparison. orasure trades for 7$ and some change and they only have one test on the market for hiv Orasure has somewhat less than 1.9 billion shares outstanding. <g> You have to look at market cap, not stock price. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next